HTLV-1 in rural Guinea-Bissau: prevalence, incidence and a continued association with HIV between 1990 and 2007.

Carla van Tienen, Maarten F Schim van der Loeff, Ingrid Peterson, Matthew Cotten, Birgitta Holmgren, Sören Andersson, Tim Vincent, Ramu Sarge-Njie, Sarah Rowland-Jones, Assan Jaye, Peter Aaby, Hilton Whittle
Author Information
  1. Carla van Tienen: Medical Research Council, Fajara, The Gambia. cvantienen@mrc.gm

Abstract

BACKGROUND: HTLV-1 is endemic in Guinea-Bissau, and the highest prevalence in the adult population (5.2%) was observed in a rural area, Caió, in 1990. HIV-1 and HIV-2 are both prevalent in this area as well. Cross-sectional associations have been reported for HTLV-1 with HIV infection, but the trends in prevalence of HTLV-1 and HIV associations are largely unknown, especially in Sub Saharan Africa. In the current study, data from three cross-sectional community surveys performed in 1990, 1997 and 2007, were used to assess changes in HTLV-1 prevalence, incidence and its associations with HIV-1 and HIV-2 and potential risk factors.
RESULTS: HTLV-1 prevalence was 5.2% in 1990, 5.9% in 1997 and 4.6% in 2007. Prevalence was higher among women than men in all 3 surveys and increased with age. The Odds Ratio (OR) of being infected with HTLV-1 was significantly higher for HIV positive subjects in all surveys after adjustment for potential confounding factors. The risk of HTLV-1 infection was higher in subjects with an HTLV-1 positive mother versus an uninfected mother (OR 4.6, CI 2.6-8.0). The HTLV-1 incidence was stable between 1990-1997 (Incidence Rate (IR) 1.8/1,000 pyo) and 1997-2007 (IR 1.6/1,000 pyo) (Incidence Rate Ratio (IRR) 0.9, CI 0.4-1.7). The incidence of HTLV-1 among HIV-positive individuals was higher compared to HIV negative individuals (IRR 2.5, CI 1.0-6.2), while the HIV incidence did not differ by HTLV-1 status (IRR 1.2, CI 0.5-2.7).
CONCLUSIONS: To our knowledge, this is the largest community based study that has reported on HTLV-1 prevalence and associations with HIV. HTLV-1 is endemic in this rural community in West Africa with a stable incidence and a high prevalence. The prevalence increases with age and is higher in women than men. HTLV-1 infection is associated with HIV infection, and longitudinal data indicate HIV infection may be a risk factor for acquiring HTLV-1, but not vice versa. Mother to child transmission is likely to contribute to the epidemic.

References

  1. PLoS Med. 2007 Oct 16;4(10):e296 [PMID: 17941714]
  2. AIDS. 1999 Apr 16;13(6):701-7 [PMID: 10397565]
  3. Retrovirology. 2006 Jun 22;3:35 [PMID: 16792805]
  4. J Infect Dis. 1995 Mar;171(3):559-65 [PMID: 7876601]
  5. J Acquir Immune Defic Syndr. 2000 Oct 1;25(2):157-63 [PMID: 11103046]
  6. Oncogene. 2005 Sep 5;24(39):6058-68 [PMID: 16155612]
  7. Int J Tuberc Lung Dis. 2007 Oct;11(10):1066-72 [PMID: 17945062]
  8. J Trop Pediatr. 1999 Apr;45(2):66-70 [PMID: 10341498]
  9. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Aug 1;9(4):422-8 [PMID: 7600111]
  10. J Acquir Immune Defic Syndr. 2002 Jul 1;30(3):342-50 [PMID: 12131572]
  11. AIDS. 2001 Nov 23;15(17):2303-10 [PMID: 11698704]
  12. J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):607-10 [PMID: 18645510]
  13. J Clin Invest. 2007 Oct;117(10):3067-74 [PMID: 17823657]
  14. PLoS One. 2007 Apr 18;2(4):e372 [PMID: 17440608]
  15. J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):269-73 [PMID: 18398969]
  16. Retrovirology. 2007 Nov 27;4:85 [PMID: 18042276]
  17. AIDS. 1996 Nov;10(13):1585-90 [PMID: 8931796]
  18. Int J Cancer. 1998 May 4;76(3):293-8 [PMID: 9579561]
  19. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jun 1;12(2):193-201 [PMID: 8680892]
  20. Scand J Infect Dis. 2000;32(2):169-75 [PMID: 10826903]
  21. AIDS. 1993 Aug;7(8):1119-22 [PMID: 8397950]
  22. J Immunol. 2005 Nov 1;175(9):6117-22 [PMID: 16237108]
  23. Proc Natl Acad Sci U S A. 2003 May 27;100(11):6588-92 [PMID: 12743376]
  24. AIDS. 2006 Jun 12;20(9):1303-11 [PMID: 16816560]
  25. PLoS One. 2006 Dec 20;1:e101 [PMID: 17183634]
  26. Scand J Infect Dis. 1999;31(5):459-66 [PMID: 10576124]
  27. Lancet Infect Dis. 2007 Apr;7(4):266-81 [PMID: 17376384]
  28. J Infect Dis. 2003 Dec 1;188(11):1648-51 [PMID: 14639534]
  29. J Neurol Neurosurg Psychiatry. 2009 Jan;80(1):66-8 [PMID: 18977823]
  30. J Infect Dis. 1996 Jan;173(1):245-8 [PMID: 8537668]
  31. Mol Biol Evol. 2001 Apr;18(4):661-71 [PMID: 11264418]
  32. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415-9 [PMID: 6261256]
  33. AIDS. 2008 Jun 19;22(10):1195-202 [PMID: 18525265]
  34. Int J Epidemiol. 2006 Oct;35(5):1322-8 [PMID: 16543363]
  35. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Nov 1;10(3):358-65 [PMID: 7552498]
  36. AIDS. 1998 Sep 10;12(13):1707-14 [PMID: 9764792]
  37. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Aug 15;15(5):381-6 [PMID: 9342259]
  38. Sex Transm Infect. 2007 Oct;83(6):463-7 [PMID: 17611233]
  39. J Acquir Immune Defic Syndr. 2010 Apr;53(5):640-7 [PMID: 19841588]
  40. J Clin Invest. 1995 Feb;95(2):852-8 [PMID: 7860769]
  41. AIDS Rev. 2009 Jan-Mar;11(1):8-16 [PMID: 19290030]
  42. Lancet. 1990 Dec 1;336(8727):1345-7 [PMID: 1978165]
  43. AIDS. 2009 Jul 31;23(12):1575-82 [PMID: 19521234]
  44. AIDS. 2009 Mar 13;23(5):637-9 [PMID: 19242315]
  45. Jpn J Cancer Res. 1998 Aug;89(8):797-805 [PMID: 9765614]
  46. AIDS. 1994 Jul;8(7):977-82 [PMID: 7946109]
  47. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jun 1;12(2):187-92 [PMID: 8680891]
  48. J Acquir Immune Defic Syndr. 2005 Dec 15;40(5):625-8 [PMID: 16284541]
  49. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 May 1;9(1):81-8 [PMID: 7712238]
  50. Int J Epidemiol. 1994 Aug;23(4):812-7 [PMID: 8002196]
  51. Jpn J Cancer Res. 1994 Mar;85(3):231-7 [PMID: 8188520]
  52. Am J Trop Med Hyg. 2005 Sep;73(3):560-5 [PMID: 16172481]
  53. J Infect Dis. 1993 Jan;167(1):57-65 [PMID: 8418183]

Grants

  1. MC_U190081997/Medical Research Council
  2. MC_U190085854/Medical Research Council

MeSH Term

Adolescent
Adult
Age Factors
Aged
Comorbidity
Cross-Sectional Studies
Female
Guinea-Bissau
HIV Infections
HIV-1
HIV-2
HTLV-I Infections
Human T-lymphotropic virus 1
Humans
Incidence
Male
Middle Aged
Prevalence
Risk Factors
Sex Factors
Young Adult